Skip to main content

Table 6 Crude Estimate Number of Patients Due for Type 2 Diabetes Screening

From: Estimated impact of COVID-19 on preventive care service delivery: an observational cohort study

 

No. in Age Range

% Eligible for Screening

# Eligible for Screening

% Due for Screening (Baseline)

No. Due for Screening

LCL 95% of % Due for Screening

LCL No. Due for Screening

UCL 95% of % Due for Screening

UCL No. Due for Screening

Study Clinics

12,402

88.2%

10,933

4.5%

489

0.2%

23

8.7%

954

Ontario

6,952,870

88.2%

6,129,000

4.5%

274,000

0.2%

13,000

8.7%

535,000

Canada

18,139,570

88.2%

15,991,000

4.5%

714,000

0.2%

34,000

8.7%

1,396,000

  1. The number of patients in the screening age range for type 2 diabetes were calculated from 2016 census data [20]. The percentage of patients eligible for screening and due for screening to return to baseline were determined from the study clinics, then used to estimate the number of patients eligible for screening in Ontario and Canada. The lower confidence level (LCL) and upper confidence level (UCL) were also determined based on the study population. Estimations for Ontario and Canada were rounded to the nearest 1000 patients